LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation.

Autor: C, Felder C, E, Joyce K, M, Briley E, M, Glass, P, Mackie K, J, Fahey K, J, Cullinan G, C, Hunden D, W, Johnson D, O, Chaney M, A, Koppel G, M, Brownstein

Publikováno v: The Journal of Pharmacology and Experimental Therapeutics; January 1998, Vol. 284 Issue: 1 p291-7, 7p